Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients.

CONCLUSION: GP73 alone appears efficient for detecting cirrhosis and superior to APRI determination. In combination with APRI, its diagnostic performance can be further improved. Most importantly, the simple GP73 measurement proved promising for predicting a worse outcome of patients with both viral and non-viral chronic liver diseases.
PMID: 32982114 [PubMed - in process]

Source: World Journal of Gastroenterology : WJG - September 13, 2020 Category: Gastroenterology Authors: Gatselis NK, Tornai T, Shums Z, Zachou K, Saitis A, Gabeta S, Albesa R, Norman GL, Papp M, Dalekos GN Tags: World J Gastroenterol Source Type: research